Medical Health & Life Science Research News

point-of-care diagnostics market examined in new market research report

Medical Market Research

The global point-of-care diagnostics market is estimated to be valued at USD 23.71 Billion in 2017 and is projected to reach USD 38.13 Billion by 2022 growing at a CAGR of 10.0%.

- Advertising -

Browse 129 tables and 36 figures spread through 226 pages and in-depth TOC on "Point-of-Care/Rapid Diagnostics Market"Browse 129 tables and 36 figures spread through 226 pages and in-depth TOC on "Point-of-Care/Rapid Diagnostics Market"  www.marketsandmarkets.com/Market-R…6829185.htmlEarly

The factors driving the growth of this market include high prevalence of infectious diseases in developing countries, increasing incidence of target diseases, and increasing inclination toward home healthcare across the globe.


Analysis of the market developments between 2015 and 2017 revealed that several growth strategies such as product launches, product approvals, acquisitions, collaborations, and expansions were adopted by market players to strengthen their product portfolios and maintain a competitive position in the point-of-care diagnostics market. Among these business strategies, product approvals and launches were the most widely adopted growth strategies by players to garner a larger share of the market and remain competitive.

- Advertising -

Roche (Switzerland) held the leadership position in the global point-of-care diagnostics market in 2016. The company has been focusing on the development of new products and technologies in the field of diagnostics.

Through this, it introduced innovative products in the market, which enabled it to garner a higher market share. In addition, the company has a strong global presence with manufacturing facilities in Europe and the US and strong distribution channels to serve markets in Europe, the Middle East, Africa, Asia Pacific, and Latin and North America.


Report: www.marketsandmarkets.com/requests….asp?id=106829185


Abbott (US) held the second position in the global point-of-care diagnostics market in 2016. The company has a diversified portfolio, which includes a wide range of diagnostics tests, immunoassays, integrated systems, antibodies, fluorescent in situ hybridization (FISH) kits, and antibodies.

The company’s key strategy is to focus on product launches, approvals, agreements, and collaborations to strengthen its portfolio and enhance its share in the global point-of-care diagnostics market. For instance, in November 2016, the company launched its i-Stat alinity system, a handheld device for blood testing.

News From

MarketsandMarkets™ - Business ResearchMarketsandMarkets™
Category: Market Research Publishers and RetailersCompany about: MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth ...
This email address is being protected from spambots. You need JavaScript enabled to view it.